Avanza Fonder Ab Vertex Pharmaceuticals Inc Transaction History
Avanza Fonder Ab
- $3.37 Trillion
- Q4 2024
A detailed history of Avanza Fonder Ab transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Avanza Fonder Ab holds 28,158 shares of VRTX stock, worth $11.7 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
28,158Holding current value
$11.7 Million% of portfolio
0.34%Shares
1 transactions
Others Institutions Holding VRTX
# of Institutions
1,719Shares Held
222MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$11.2 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$9.66 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.89 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.93 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$3.75 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $107B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...